Get to know Nuclear Medicine Physician Dr. John P. Seibyl, who serves patients in New Haven, Connecticut.
Dr. Seibyl, a board-certified nuclear medicine physician, serves as the Executive Director, Senior Scientist, and Chairman of the Board at the Institute for Neurodegenerative Disorders in New Haven, Connecticut.
In 2001, he co-founded the Institute for Neurodegenerative Disorders alongside Dr. Kenneth Marek as a non-profit, independent clinical imaging research facility. Their goal was to create a unique clinical research company that combines excellence in clinical neuroscience with state-of-the-art imaging to develop improved tools for the diagnosis and treatment of Parkinson’s disease, Alzheimer’s disease, and other neurologic conditions. Along with a team of expert researchers, the facility is actively involved in novel clinical studies, offering the potential to slow neurological disease or even restore neurological function.
Recognized as an international expert on PET and SPECT imaging for neurodegenerative disorders, Dr. Seibyl also serves as the Managing Director of Molecular NeuroImaging, a Division of inviCRO, and as the Chairman of the Board & President of the Trinity Institute For Applied Neuroscience And Spirituality.
Prior to his current endeavors, he served as the Co-Founder & President of Molecular NeuroImaging, the Director of the NeuroSPECT Center at Yale University, the Chief of the Section of Nuclear Medicine and Director of the Yale PET Center (1996-2001), and an Associate Clinical Professor of Diagnostic Radiology at Yale University School of Medicine.
After earning his medical degree from the Case Western Reserve University School of Medicine in 1986, Dr. Seibyl trained as a post-doctoral fellow in the Department of Psychiatry at Yale University, where he won the Seymour Lustman Research Prize for two consecutive years. He then joined the faculty as an Assistant Professor upon the completion of his training.
While on the psychiatry faculty, his interest in brain imaging led to his returning for a training fellowship in nuclear medicine at Yale under Dr. Paul Hoffer. He was recruited to the Diagnostic Radiology faculty and was appointed the Director of the NeuroSPECT Center, a clinical brain imaging research lab in the Section of Nuclear Medicine. He subsequently became Chief of the Section of Nuclear Medicine and Director of the Yale / VA PET Center.
The doctor is board-certified in nuclear medicine by the American Board of Nuclear Medicine, which certifies physicians as specialists in the practice of nuclear medicine. In addition, he is board-certified in psychiatry by the American Board of Psychiatry and Neurology, which is a not-for-profit corporation dedicated to serving the public interest and the professions of psychiatry and neurology by promoting excellence in practice through certification and maintenance of certification processes.
To stay current with the latest advances in his field, Dr. Seibyl remains a distinguished member of the Society of Nuclear Medicine and Molecular Imaging, the Brain Imaging Council, and the Society of Nuclear Medicine-New York Chapter – from all of which he is a former President. He was awarded the 2015 Kuhl-Lassen Award by the Society of Nuclear Medicine and Molecular Imaging for outstanding contributions to the advancement of molecular imaging.
Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear medicine physicians are medical specialists who use tracers, usually radiopharmaceuticals, for diagnosis and therapy. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy.
With an impressive professional journey that spans over three decades, Dr. Seibyl has won numerous grants and contracts in the context of his work in brain imaging, publishing over 250 articles, book chapters, and case reports. He serves on the editorial board of the European Journal of Nuclear Medicine and is a frequent reviewer for top-tier nuclear imaging journals.
Furthermore, he serves on international panels for his work in neurodegenerative disease imaging, working closely with Dr. Marek to establish the NeuroSPECT Center as the premier Parkinson’s disease brain imaging research center in the world. Recent projects include the development of a web-based normal brain image database, and on-going work applying brain imaging techniques and analytic methods to improve the diagnosis and assessment of disease status in patients with neurodegenerative diseases.
With a passion for his field, Dr. Seibyl attributes his success to his ability and interest to continue learning and find new details about the brain. In his free time, he enjoys distance running.
Learn More about Dr. John P. Seibyl:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/8129567-John-Seibyl-nuclear-medicine-specialist-New-Haven-Connecticut-06510 or through Institute for Neurodegenerative Disorders, https://www.indd.org/meettheteam.htm
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know how to make informed decisions for you and your family.